Indicated for: ocular inflammation
Route of administration: ophthalmic
Substance: fluorometholone + tetrahydrozoline (anti-inflammatory agents)
ATC: S01BB03 (Sensory organs | Antiinflammatory agents | Corticosteroids and mydriatics in combination)
Fluorometholone and tetrahydrozoline are used together in ophthalmic medications for the treatment of eye inflammation associated with congestion and irritation. This combination is indicated for conditions such as allergic conjunctivitis, eye irritation caused by external factors (dust, smoke, pollen), or other minor eye inflammations.
- Fluorometholone is a corticosteroid with anti-inflammatory properties that reduces inflammation, redness, and swelling in the eyes. It works by inhibiting the body's inflammatory response, alleviating symptoms associated with allergies or eye irritation.
- Tetrahydrozoline is a decongestant that acts by constricting blood vessels in the eyes, quickly reducing redness and ocular congestion. This effect helps relieve discomfort and improve the appearance of the eyes.
While effective, this combination may cause some side effects. The most common include a burning or stinging sensation upon application, dry eyes, or temporary blurred vision. In rare cases, prolonged use of corticosteroids can lead to increased intraocular pressure, cataracts, or secondary eye infections. It is important that the treatment is used short-term and under medical supervision.
This combination should be used as directed by a doctor, and patients should adhere to the prescribed dosage and duration of treatment. It is contraindicated in patients with active eye infections (bacterial, viral, or fungal) or hypersensitivity to any of the components. If symptoms persist or worsen, an immediate ophthalmological consultation is necessary.